𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis B virus vaccine failure resulting in chronic hepatitis B infection

✍ Scribed by J.A. O’Halloran; C.F. De Gascun; L. Dunford; M.J. Carr; J. Connell; R. Howard; W.W. Hall; J.S. Lambert

Book ID
116632131
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
211 KB
Volume
52
Category
Article
ISSN
1386-6532

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Leucocyte hepatitis B virus DNA in acute
Leucocyte hepatitis B virus DNA in acute and chronic hepatitis B virus infection
✍ F. Davison; G. J. M. Alexander; Ch. Anastassakos; E. A. Fagan; Roger Williams 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 1 views

In the present study we have investigated 53 patients with a spectrum of acute and chronic hepatitis B virus (HBV) infection for the presence of leucocyte HBV-DNA with the aid of molecular techniques. HBV-DNA was detected in peripheral blood mononuclear cells of 31 of 45 (69%) of chronic HBsAg carri

Acyclovir in chronic hepatitis B virus i
Acyclovir in chronic hepatitis B virus infection
✍ Geoffrey M. Dusheiko 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 2 views

In a previous study a partial inhibition of viral replication was observed in HBeAg-positive patients after acyclovir (ACV) treatment. To assess those results and to evaluate different treatment regimens, a randomized controlled trial with ACV given at 45 mg/kg/day by continuous infusion (in 5 pati

AFP in chronic hepatitis B virus infecti
AFP in chronic hepatitis B virus infection
✍ Yun-Fan Liaw; Anna Lok 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

to be controlled for in comparing immunoprophylactic approaches. At present, DNA polymerase activity or HBV DNA is useful for estimating the level of exposure. In an editorial in this issue, Dr. Dienstag pointed out difficulties in comparing the results of two immunoprophylactic regimens conducted a